Investor relations

Presentations

Shareholders

Shareholder Information

As of 1.3.2017

Top 20 shareholders of Lytix Biopharma AS
Shareholder Number of shares % of shares +/- shares
last month
North Murray AS* 160 572
16.0
Picasso Kapital AS* 122 189
12.2
TAJ Holding AS
78 519
7.8
CARE Holding AS
75 230
7.5
Norinnova Invest AS 48 766
4.9
Lysnes Invest AS 43 245 4.3
Hopen Invest AS 29 487
2.9
3 T PRODUKTER 25 730
2.6
Per Strand Eiendom AS 19 627
2.0
4LB INVEST AS 17 812
1.8
Nordinnova Technology Transfer AS
17 339
1.7
John Sigurd Svendsen* 16 964
1.7
Sparebank1 Nord-Norge Portefølge AS 16 897 1.7
Innovasjon Norge AS
14 890
1.5
Rekdal* 11 736
1.2
Tave Invest AS 11 722
1.2
Kræmer A/S
10 598 1.1
Troms Kraft AS 10 432 1.0
Harila Invest AS 10 315
1.0
Øksnes Invest AS 9 035
0.9
Other shareholders 251 701
25.1
Total 1 002 806
100.0

*Companies where members of the board and/or management of Lytix Biopharma AS are represented.

Trades among insiders of Lytix Biopharma AS last month:
(E = Shares emisson, SO = Share Options)



* List of insiders within the Board and Management
Lytix Biopharma Board:                      Lytix Biopharma Management:
Gert Munthe, Chairman                      Håkan wickholm, CEO
Knut Eidissen, member                       Øystein Rekdal, Co-founder and CSO
Kari Grønås, member                         Wenche Marie Olsen, COO
John Sigurd Svendsen, member           Andrew Saunders, CMO
Lena Torlegård, member                     Kjetil Vangsnes, CFO
Morten Jurs, member                        
Debasish Roychowdhury, member